Massachusetts General Hospital ( Site 0102)

Boston, Massachusetts 02114

0 studies enrolling now · 1 studies all time

What they study most

Advanced Melanoma

Studies at this site

• Immunologic Determinants of Response to Pembrolizumab (MK-3475) in Advanced Melanoma (MK-3475-161/KEYNOTE-161) — Stopped early